Relative bioavailability of coenzyme Q10 in emulsion and liposome formulations

Biomolecules and Therapeutics

Volumn 18, Issue 1, 2010, Pages 99-105

  Choi, Chee Ho ^a   Kim, Si Hun ^a   Shanmugam, Srinivasan ^b   Baskaran, Rengarajan ^b   Park, Jeong Sook ^a   Yong, Chul Soon ^b   Choi, Han Gon ^b   Yoo, Bong Kyu ^b   Han, Kun ^a  

^a Chungbuk National University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

Bioavailability; Coenzyme Q10; Liposome; Pharmacokinetic parameters; Photostability

Indexed keywords

1,2 DIMYRISTOYL SN GLYCERO 3 PHOSPHATE MONOSODIUM; 1,2 DIOLEOYL 3 TRIMETHYLAMMONIUM PROPANE CHLORIDE; ANION; CATION; CHOLESTEROL; EMULSIFYING AGENT; LIPOSOME; PHOSPHOLIPON 85G; UBIDECARENONE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG FORMULATION; EMULSION; HYDRATION; LIPID MEMBRANE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; RAT; SINGLE DRUG DOSE;

RATTUS;

EID: 76749169367     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2010.18.1.099     Document Type: Article

References (33)

1. Bhagavan, H. N. and Chopra, R. K. (2006). Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research 40, 445-453.
2. Bonakdar, R. A. and Guarneri, E. (2005). Coenzyme Q10. Am. Fam. Physician 72, 1065-1070.
3. Bonuccelli, U. and Del Dotto, P. (2006). New pharmacologic horizons in the treatment of Parkinson disease. Neurology 67, S30-38.
4. Buettner, C., Phillips, R., Davis, R., Gardiner, P. and Mittleman, M. (2007). Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am. J. Cardiol. 99, 661-666.
5. Conklin, K. (2005). Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr. Cancer Ther. 4, 110-130.
6. Crane, F. (2001). Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 20, 591-598.
7. Ferrante, K., Shefner, J., Zhang, H., Betensky, R., O'Brien, M., Yu, H., Fantasia, M., Taft, J., Beal, M., Traynor, B., Newhall, K., Donofrio, P., Caress, J., Ashburn, C., Freiberg, B., O'Neill, C., Paladenech, C., Walker, T., Pestronk, A., Abrams, B., Florence, J., Renna, R., Schierbecker, J., Malkus, B. and Cudkowicz, M. (2005). Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology 65, 1834-1836.
8. Greenberg, S. and Frishman, W. H. (1990). Co-enzyme Q10: a new drug for cardiovascular disease. J. Clin. Pharmacol. 30, 596-608.
9. Hodgson, J., Watts, G., Playford, D., Burke, V. and Croft, K. (2002). Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur. J. Clin. Nutr. 56, 1137-1142.
10. Hsu, C. H., Cui, Z., Mumper, R. J. and Jay, M. (2003). Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS Pharm. Sci. Tech. 4, E32.
11. Hyun, D., Emerson, S., Jo, D., Mattson, M. and De Cabo, R. (2006). Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc. Natl. Acad. Sci. USA 103, 19908-19912.
12. Janson, M. (2006). Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging. Clin. Interv. Aging 1. 261-265.
13. Littarru, G. and Tiano, L. (2005). Clinical aspects of coenzyme Q10: an update. Curr. Opin. Clin. Nutr. Metab. Care 8, 641-646.
14. Kurowska, E. M., Dresser, G., Deutsch, L., Bassoo, E. and Freeman, D. J. (2003). Relative bioavailability and anti-oxidant potential of two coenzyme q10 preparations. Ann. Nutr. Metab. 47, 16-21.
15. Laaksonen, R., Ojala, J., Tikkanen, M. and Himberg, J. (1994). Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors. Eur. J. Clin. Pharmacol. 46, 313-317.
16. Leonhauser, S., Lebold, K., Krisch, K., Standinger, H., Gale, F., Page, A. Jr. and Folkers, K. (1962). On the presence and significance of coenzyme Q in microsomes. Arch. Biochem. Biophys. 96, 580-586.
17. Levy, G., Kaufmann, P., Buchsbaum, R., Montes, J., Barsdorf, A., Arbing, R., Battista, V., Zhou, X., Mitsumoto, H., Levin, B. and Thompson, J. (2006). A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology 66, 660-663.
18. Liu, Z. X. and Artmann, C. (2009). Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. Altern. Ther. Health Med. 15, 42-46.
19. Makabi-Panzu, B., Sprott, G. D. and Patel, G. B. (1998). Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein. Vaccine 16, 1504-1510.
20. Ratnam, D., Ankola, D., Bhardwaj, V., Sahana, D. and Kumar, M. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J. Control. Rel. 113, 189- 207.
21. Roffe, L., Schmidt, K. and Ernst, E. (2004). Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: a systematic review. J. Clin. Oncol. 22, 4418-4424.
22. Sassi, S., Genova, M. and Lenaz, G. (1994). Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Int. J. Clin. Lab. Res. 24, 171-176.
23. Schulz, C., Obermüller-Jevic, U. C., Hasselwander, O., Bernhardt, J. and Biesalski, H. K. (2006). Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10). Int. J. Food Sci. Nutr. 57, 546-555.
24. Shults, C., Flint Beal, M., Song, D. and Fontaine, D. (2004). Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp. Neurol. 188, 491-494.
25. Shults, C. and Haas, R. (2005). Clinical trials of coenzyme Q10 in neurological disorders. Biofactors 25, 117-126.
26. Singh, U., Devaraj, S. and Jialal, I. (2007). Coenzyme Q10 supplementation and heart failure. Nutr. Rev. 65, 286-293.
27. Smith, K., Matson, S., Matson, W., Cormier, K., Del Signore, S., Hagerty, S., Stack, E., Ryu, H. and Ferrante, R. (2006). Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochim. Biophys. Acta 1762, 616-626.
28. Sun, I., Sun, E., Crane, F., Morro, D., Lindgren, A. and Low, H. (1992). Requirement for coenzyme Q in plasma membrane electron transport. Proc. Natl. Acad. Sci. USA 89, 11126-11130.
29. Tomono, Y., Hasegawa, J., Seki, T., Motegi, K. and Morishita, N. (1986). Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man. Int. J. Clin. Pharmacol. Ther. Toxicol. 24, 536-541.
30. Tran, M. T., Mitchell, T. M., Kennedy, D. T. and Giles, J. T. (2001). Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy 21, 797-806.
31. Yang, H., Lin, S., Huang, S. and Chou, H. (2005). Acute administration of red yeast rice (Monascus purpureus) depletes tissue coenzyme Q(10) levels in ICR mice. Br. J. Nutr. 93, 131-135.
32. Young, J., Florkowski, C., Molyneux, S., McEwan, R., Frampton, C., George, P. and Scott, R. (2007). Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am. J. Cardiol. 100, 1400-1403.
33. Zmitek, J., Smidovnik, A., Fir, M., Prosek, M., Zmitek, K., Walczak, J. and Pravst, I. (2008). Relative bioavailability of two forms of a novel water-soluble coenzyme Q10. Ann. Nutr. Metab. 52, 281-287.